A carregar...
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Systemic therapy for hepatocellular carcinoma (HCC) has changed drastically since the introduction of the molecular targeted agent sorafenib in 2007. Although sorafenib expanded the treatment options for extrahepatic spread (EHS) and vascular invasion, making long-term survival of patients with adva...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6266463/ https://ncbi.nlm.nih.gov/pubmed/30380773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10110412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|